글로벌 척추관 협착증 치료 시장 – 2030년까지의 산업 동향 및 예측

척추관 협착증 치료 시장 분석 및 규모

2023-2030년 예측 기간 동안 글로벌 척추관 협착증 치료 시장 성장을 촉진할 것으로 예상되는 주요 요인은 노인 인구의 증가입니다. 또한 척추 변형으로 고통받는 비만 인구가 증가함에 따라 글로벌 척추관 협착증 치료 시장 성장이 더욱 촉진될 것으로 예상됩니다. 또한 퇴행성 척추측만증 및 퇴행성 척추분리증을 포함한 척추 질환의 증가는 글로벌 척추관 협착증 치료 시장 성장을 더욱 완화할 것으로 추산됩니다. 반면, 수술 치료 비용의 증가는 2023-2030년 타임라인 기간 동안 글로벌 척추관 협착증 치료 시장 성장을 더욱 방해할 것으로 예상됩니다.                       

Data Bridge Market Research는 2022년에 94억 5천만 달러였던 글로벌 척추관 협착증 치료 시장이 2030년까지 135억 4천만 달러에 도달할 것으로 예상하고, 2023-2030년 예측 기간 동안 4.60%의 CAGR을 기록할 것으로 분석했습니다. 이는 시장 가치를 나타냅니다. "수술"은 척추 수술 건수의 증가로 인해 글로벌 척추관 협착증 치료 시장의 치료 부문을 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

척추관 협착증 치료 시장 범위 및 세분화

시장 정의

척추관 협착증은 척추관이나 척추의 신경 개구부가 좁아져 척수나 신경에 압박을 가하는 의학적 질환입니다. 일반적으로 허리(요추 척추관 협착증)나 목(경추 척추관 협착증)에 발생하며 통증, 무감각, 쇠약, 걷기 어려움과 같은 증상을 유발할 수 있습니다. 치료 옵션은 물리 치료 및 약물과 같은 보수적 접근 방식에서 척추 절제술이나 척추 융합과 같은 외과적 개입까지 다양하며, 이는 상태의 심각성과 개별 환자의 필요에 따라 달라집니다.

글로벌 척추관 협착증 치료 시장 역학

운전자

• 생활 습관의 변화

앉아서 지내는 행동, 비만, 나쁜 자세와 같은 라이프스타일 요인은 척추관 협착증 발병 위험 증가와 관련이 있습니다. 이러한 요인이 인구의 상당 부분에 계속 영향을 미치면서 예방 조치와 치료 옵션에 대한 필요성이 증가하고 있으며, 척추관 협착증 치료에 대한 수요가 증가하고 있습니다.

• 기술의 발전

최소 침습 수술 기법, 개선된 영상 모달리티, 혁신적인 척추 임플란트 및 장치 개발을 포함한 의료 기술의 발전으로 척추관 협착증 치료 옵션 범위가 확대되었습니다. 이러한 발전은 보다 효과적이고 덜 침습적인 치료 옵션을 제공함으로써 시장 성장을 촉진하고 있습니다.

• 인식 및 진단 증가 

Increased awareness of spinal stenosis among healthcare professionals and patients, along with improved diagnostic capabilities, has led to earlier and more accurate diagnoses. This has resulted in a higher number of individuals seeking treatment for the condition, contributing to market expansion.

• Aging Population and Disease burden

The global population is aging, leading to a higher prevalence of spinal stenosis as it is commonly associated with age-related degenerative changes. As the elderly population increases, the demand for spinal stenosis treatment options, both non-surgical and surgical, is expected to grow.  

Opportunities

• Increased Demand for Minimally Invasive Procedures

The demand for minimally invasive surgical techniques, such as endoscopic spine surgery and minimally invasive decompression, is increasing. These procedures offer faster recovery times, reduced post-operative pain, and shorter hospital stays. There is a significant opportunity for companies to develop and market advanced minimally invasive technologies for spinal stenosis treatment.

• Telemedicine and Remote Monitoring

The adoption of telemedicine and remote patient monitoring has accelerated, offering opportunities for providing ongoing care and monitoring for individuals with spinal stenosis. Telehealth solutions, combined with wearable devices and remote monitoring platforms, can improve patient management and adherence to treatment plans while reducing healthcare costs.

Restraints/Challenges

• High Treatment Costs

The cost of spinal stenosis treatment, particularly surgical interventions and advanced medical devices, can be prohibitively high for many patients. This financial barrier can limit access to treatment options and restrain market growth, especially in regions with inadequate healthcare coverage.

• Stringent Regulatory Approvals

Regulatory approval for new medical devices and treatments in the spinal stenosis market can be a lengthy and costly process. Stringent regulatory requirements and clinical trials may slow down the introduction of innovative therapies and devices, hampering market growth.

• Limited insurance coverage

In some healthcare systems, insurance coverage for spinal stenosis treatment may be limited or not comprehensive. Patients may face difficulties in obtaining reimbursement for necessary procedures, which can discourage them from seeking treatment or opting for less expensive alternatives.

• Potential complications

Spinal stenosis treatments, especially surgical procedures, carry risks of complications and adverse events. Concerns about potential complications, such as infection or nerve damage, may deter some patients from undergoing treatment, leading to underutilization of available therapies.

This global spinal stenosis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global spinal stenosis treatment market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In January 2022, Food and Drug Administration approved new expanded magnetic resonance imaging (MRI) compatibility for Abbott’s Proclaim XR Spinal Cord Stimulation (SCS) System with Octrode Leads
• In July 2022, Calyx and Qynapse have joined forces to expand the use of artificial intelligence (AI)-based neuroimaging tools in clinical trials of treatment candidates for conditions affecting the central nervous system (CNS), or the brain and spinal cord

Global Spinal Stenosis Treatment Market Scope

The global spinal stenosis treatment market is segmented on the basis of type, treatment, drugs class, drugs, route of administration, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Cervical stenosis
• Lumbar stenosis

Treatment

• Synthetic material
• Biologically derived material
• Genetically engineered material
• Pharmaceutical

Drug Class

• Analgesics
• Antidepressants
• Anti-seizures
• Corticosteroid
• Others

Drugs

• Naproxen
• Amitriptyline
• Gabapentin
• Oxycodone
• Others

Route of Administration

• Oral
• Intravenous
• Intraspinal
• Others

Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

End User

• Hospitals
• Homecare
• Specialty clinics
• Others.

Global Spinal Stenosis Treatment Market Regional Analysis/Insights

The global spinal stenosis treatment market is analysed and market size insights and trends are provided by country, type, treatment, drugs class, drugs, route of administration, distribution channel and end user as referenced above.

The countries covered in the global spinal stenosis treatment market report are U.S., Canada, and Mexico in North America, Peru, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).

North America dominates the global spinal stenosis treatment market due to the rise in the aging population. Furthermore, the occurrence of major key players will further boost the growth of the global spinal stenosis treatment market in the region during the forecast period 2023-2030. Asia-Pacific is projected to observe significant amount of growth in the global spinal stenosis treatment market due to the increase in the geriatric population. Moreover, the rise in the number of hospitals that are offering surgical treatment for spinal stenosis and increasing health care expenses is further anticipated to propel the growth of the global spinal stenosis treatment market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global spinal stenosis treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global spinal stenosis treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global spinal stenosis treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Spinal Stenosis Treatment Market Share Analysis

글로벌 척추관 협착증 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 척추관 협착증 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 척추관 협착증 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 멀린크로트(영국)
• 영진약품(한국)
• 오노제약 주식회사(일본)
• 스미토모 다이닛폰 제약 주식회사(일본)
• NIPPON SHINYAKU CO., LTD (일본)
• 다이쇼제약 주식회사(일본)
• RTI Surgical Holdings, Inc(미국)
• 메드트로닉(아일랜드)
• 존슨앤존슨 서비스 주식회사(미국)
• Empirical Spine, Inc(미국)
• Alphatec Spine, Inc(미국)
• B. Braun Melsungen AG(독일)
• Exactech, Inc (미국)
• Globus Medical Inc (미국)
• NuVasive, Inc(미국)
• 오쏘픽스 홀딩스(미국)
• 스트라이커(미국)
• 짐머 바이오멧(미국)
• 파이저 주식회사(미국)
• Vertos Medical Inc (미국)
• 엔도제약(아일랜드)  

SKU-50477